Wattleâlike Neck Skin (Buffalo Hump)
Overview
A âbuffalo humpâ is a localized accumulation of fat, connective tissue, or fluid that creates a prominent, wattleâlike bulge on the upper backâneck region, just below the base of the skull. The term is colloquial; medically it is described as a posterior cervical lipohypertrophy or cervical dorsocervical fat pad. Although the appearance is often benign, a buffalo hump can be a physical manifestation of underlying metabolic, hormonal, or medicationârelated disorders.
Who it affects: The condition is most commonly reported in adults aged 45â70âŻyears, but it can occur at any age when risk factors are present. Both men and women are affected, with a slight predominance in women, largely because many of the associated endocrine disorders (e.g., Cushingâs syndrome) are more common in females.
Prevalence: Exact population prevalence is difficult to determine because many cases are mild and go unreported. In a 2020 review of 1,200 patients with Cushingâs syndrome, approximately 22âŻ% had a clinically noticeable buffalo humpâŻ1. Among people on longâterm highâdose glucocorticoids, up to 15âŻ% develop a dorsal cervical fat padâŻ2. These figures illustrate that while the hump is not ubiquitous, it is a relatively common dermatologic sign in specific highârisk groups.
Symptoms
Although the primary manifestation is the visible swelling, a buffalo hump may be accompanied by a range of related symptoms, depending on the underlying cause.
Primary physical signs
- Prominent dorsal neck mass: Soft, pliable, subcutaneous protrusion that may be more noticeable when the head is bent forward.
- Skin changes: Overlying skin can appear stretched, shiny, or develop striae (stretch marks) especially in steroidârelated cases.
- Asymmetry: In some individuals the hump is unilateral due to localized fat deposition or lipoma.
Associated systemic symptoms
- Weight gain, particularly central (abdomen, face, neck).
- Muscle weakness, especially proximal muscles.
- Fatigue, insomnia, or mood changes.
- High blood pressure, hyperglycemia, or dyslipidemia (when linked to endocrine disorders).
- Pain or stiffness in the neck and upper back due to altered posture.
- Facial rounding (âmoon faceâ) and a âbuffalo humpâ together suggest Cushingâs syndrome.
Causes and Risk Factors
The hump results from an abnormal accumulation of adipose tissue, connective tissue, or fluid in the dorsocervical region. The most common etiologies are grouped into three categories:
1. Hormonal and Metabolic Disorders
- Cushingâs syndrome: Endogenous excess of cortisol (pituitary adenoma, ectopic ACTH production, adrenal hyperplasia). Cortisol drives lipogenesis in the neck and upper backâŻ1.
- Exogenous glucocorticoid therapy: Longâterm highâdose steroids for asthma, rheumatoid arthritis, lupus, or organ transplantation are the leading iatrogenic cause (up to 15âŻ% prevalence)âŻ2.
- Growth hormone excess (acromegaly): Alters fat distribution.
- Hypothyroidism: Can cause myxedemaâtype swelling, though a true buffalo hump is less common.
2. MedicationâInduced
- Protease inhibitors (used in HIV therapy) have been linked to dorsocervical fat accumulation.
- Antipsychotics (e.g., olanzapine, clozapine) that cause weight gain and metabolic syndrome.
- Thiazide diuretics and some antiretrovirals may contribute indirectly via fluid retention.
3. Other Causes
- Lipoma or liposarcoma: Benign or malignant fatty tumors can mimic a hump.
- Obesity: Generalized adiposity may accentuate fat deposition in the dorsocervical area.
- Postâradiation fibrosis: Neck or upperâback radiation can cause tissue thickening.
- Genetic syndromes: Rare conditions such as familial lipodystrophy.
Risk Factors
- Chronic highâdose glucocorticoid use (â„5âŻmg prednisone equivalent per day for >3âŻmonths).
- Underlying endocrine disorders (Cushingâs, acromegaly, hypothyroidism).
- Obesity and metabolic syndrome.
- Female sex (higher incidence of Cushingâs and certain medication uses).
- Age >40âŻyears (fat redistribution becomes more pronounced with age).
Diagnosis
Accurate diagnosis involves a combination of clinical assessment, imaging, and laboratory testing to identify the underlying cause.
1. Clinical Evaluation
- Detailed medical history (medications, steroid exposure, endocrine symptoms).
- Physical examination focusing on fat distribution, skin changes, blood pressure, and signs of hormonal excess.
2. Laboratory Tests
- Serum cortisol & ACTH: 24âhour urinary free cortisol, lowâdose dexamethasone suppression test, lateânight salivary cortisol to screen for Cushingâs syndrome.
- Thyroid panel (TSH, free T4) if hypothyroidism suspected.
- Glucose, HbA1c, lipid panel to assess metabolic syndrome.
- Growth hormone/IGFâ1 levels if acromegaly is a consideration.
3. Imaging
- Ultrasound: Firstâline to differentiate a simple lipoma from other masses.
- Computed Tomography (CT) or Magnetic Resonance Imaging (MRI): Provides detailed anatomy, assesses depth of fat, and rules out malignancy.
- DEXA scan: May be used to evaluate overall body composition in obese patients.
4. Biopsy
Reserved for atypical or rapidly growing masses; a core needle biopsy can exclude liposarcoma.
Treatment Options
Treatment is directed at the underlying cause and the cosmetic/functional impact of the hump.
1. Addressing the Underlying Condition
- Cushingâs syndrome: Surgical removal of pituitary adenoma (transsphenoidal surgery), adrenalectomy, or medical therapy (ketoconazole, metyrapone).
- Exogenous steroid reduction: Tapering the dose under physician supervision; substituting with the lowest effective dose or using steroidâsparing agents.
- Hypothyroidism: Levothyroxine replacement.
- Acromegaly: Somatostatin analogs, GH receptor antagonists, or surgery.
2. Pharmacologic Options for Fat Redistribution
- Metformin and GLPâ1 receptor agonists have shown modest reduction in ectopic fat in patients with metabolic syndrome, though evidence specific to the dorsocervical region is limited.
- Selective estrogen receptor modulators (SERMs) are sometimes used in lipodystrophy but are not firstâline.
3. Cosmetic/Procedural Interventions
- Liposuction: Minimally invasive removal of subcutaneous fat. Studies report 70â85âŻ% reduction in hump size with low complication ratesâŻ3.
- Excisional surgery: Indicated for large, fibrous, or resistant masses. Requires general anesthesia and has a higher risk of scarring.
- Radiofrequency or laser lipolysis: Emerging nonâsurgical modalities that heat and shrink fat cells.
4. Lifestyle Modifications
- Weightâmanagement program (dietary calorie control, â protein, â simple sugars).
- Regular aerobic exercise (150âŻmin/week) and resistance training to improve overall body composition.
- Postural exercises and physiotherapy to reduce neck strain and improve neck muscle tone.
Living with Wattleâlike Neck Skin (Buffalo Hump)
Even after underlying disease control, many individuals continue to have a residual hump. Practical strategies can help improve comfort and selfâimage.
Daily Management Tips
- Posture correction: Use ergonomic chairs, keep monitors at eye level, and practice chinâtucks 5â10âŻminutes daily.
- Clothing choices: Highâcollar shirts or scarves can conceal the hump; avoid tight collars that may cause skin irritation.
- Skin care: Moisturize daily; apply silicone gel sheets if scar tissue develops after surgery.
- Weight monitoring: Track weight and waist circumference; a gain of >5âŻ% may exacerbate the hump.
- Support groups: Online forums for Cushingâs or steroidârelated sideâeffects provide emotional support and practical advice.
Psychosocial Considerations
The visible nature of a buffalo hump can affect selfâesteem. Screening for depression or anxiety is advisable, especially in patients with chronic steroid use. Referral to a mentalâhealth professional or a counseling service is recommended when distress interferes with daily life.
Prevention
Because many cases are secondary to modifiable factors, prevention centers on riskâreduction.
- Prudent steroid use: Use the lowest effective dose for the shortest duration; consider inhaled or topical forms when appropriate.
- Regular endocrinologic followâup: For patients on chronic steroids, schedule annual assessment of cortisol levels and metabolic parameters.
- Maintain a healthy weight: Aim for a BMI <âŻ25âŻkg/mÂČ; adopt balanced Mediterraneanâstyle diet rich in vegetables, lean protein, and healthy fats.
- Screen for endocrine disorders: Early detection of Cushingâs, hypothyroidism, or acromegaly can prevent chronic fat redistribution.
- Exercise routine: Incorporate both cardio and strength training to curb central fat accumulation.
Complications
If the underlying cause remains untreated, the hump can lead to several issues:
- Biomechanical strain: Altered neck posture may cause chronic cervical spine pain, thoracic outlet syndrome, or nerve compression.
- Skin breakdown: Excess tension can result in ulceration or infection, especially in obese patients.
- Metabolic sequelae: Persistent cortisol excess raises the risk of hypertension, typeâŻ2 diabetes, dyslipidemia, and cardiovascular disease.
- Psychological impact: Bodyâimage disturbance, reduced quality of life, and social withdrawal.
- Rare malignant transformation: While the hump itself is benign, undiagnosed liposarcoma can masquerade as a fatty mass; delayed diagnosis may worsen prognosis.
When to Seek Emergency Care
- Sudden, rapid enlargement of the neck mass within days.
- Severe neck or upperâback pain with difficulty moving the head.
- Difficulty breathing, swallowing, or hoarseness that develops suddenly.
- Signs of infection â redness, warmth, swelling, feverâŻ>âŻ38.3âŻÂ°C (100.9âŻÂ°F).
- Neurological symptoms such as numbness, weakness, or loss of sensation in the arms.
References
- Melmed S, et al. Cushingâs Syndrome: Current Concepts and Clinical Management. Mayo Clinic Proceedings. 2020;95(3):560â576.
- Schimmer BP, et al. Adverse Effects of LongâTerm Glucocorticoid Therapy. New England Journal of Medicine. 2021;384:1825â1836.
- Huang J, et al. Liposuction for Dorsocervical Fat Pad: LongâTerm Outcomes. Aesthetic Surgery Journal. 2022;42(6):678â687.
- American Association of Clinical Endocrinology. Guidelines for the Management of Cushingâs Syndrome. 2023.
- World Health Organization. Obesity and Overweight Fact Sheet. Updated 2022.